Disturbance of neurotransmitter metabolism in drug-naïve, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts
Authors:
- 11 April 2022
- journal article
- research article
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 272 (7) , 1283-1296
Abstract
Neurotransmitter metabolism plays a critical role in the pathophysiology of major depressive disorder (MDD). However, whether the neurotransmitter metabolism in adolescent MDD is differentiated from adult MDD is still elusive. In the current study, plasma concentrations of monoamine and amino acid neurotransmitters as well as their metabolites, including tryptophan (TRP), kynurenine (KYN), kynurenic acid (KYNA), serotonin (5-HT), 5-hydroxyindoleacetic acid (5-HIAA), dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), norepinephrine (NE), vanillylmandelic acid (VMA), 3-methoxy-4-hydroxyphenylglycol (MHPG), glutamine (GLN), glutamate (GLU) and gamma-aminobutyric acid (GABA), were measured and compared in two cohorts of subjects (adult cohort: 31 first-episode MDD vs. 35 healthy controls; adolescent cohort: 33 first-episode MDD vs. 30 healthy controls). To assess the effects of antidepressant treatment, we also analyzed the concentrations of these indexes pre- and post-treatment in adult and adolescent cohorts. At baseline, the deficits of neurotransmitter metabolism in adult MDD were manifested in all the neurotransmitter systems. In contrast, for adolescent MDD, the dysregulation of neurotransmission was mainly indicated in the catecholaminergic systems. After antidepressant treatment, adult MDD showed increased TRP, KYN, KYNA and GLU levels, together with decreased levels of 5-HIAA and DOPAC. Adolescent MDD illustrated an increased level of 5-HT and decreased levels of TRP and GABA. The improvements of Hamilton total scores correlated with the changes in plasma TRP and the turnover of KYN/TRP after treatment in all MDD patients. However, these correlations were only manifested in the adult MDD rather than in adolescent MDD patients. The findings highlight the shared and distinguished neurotransmitter pathways in MDD and emphasize the different antidepressant responses between adults and adolescents. Potentially, the neurotransmitters above could serve as diagnostic biomarkers and provide a novel pharmacological treatment strategy for MDD.Keywords
Funding Information
- Natural Science Foundation of Hunan Province (2021JJ30922)
- Natural Science Foundation of Xinjiang Uygur Autonomous Region (2019D01A13)
- Hunan Provincial Health Commission Research Project (202113010595)
- Wu Jieping Medical Foundation Funded Special Clinical Research Project (320.6750.2020-04-2)
- Changsha Municipal Natural Science Foundation (kq2007045)
- Science and Technology Major Project of Hunan Provincial Science and Technology Department (2020SK2123)
- Fundamental Research Funds for the Central Universities of Central South University (2019zzts1049, 2020zzts884, 2021zzts1073)
- Fundamental Research Funds for Central Universities of the Central South University ((No. [2021]94))
This publication has 58 references indexed in Scilit:
- Hippocampal protein expression is differentially affected by chronic paroxetine treatment in adolescent and adult rats: a possible mechanism of “paradoxical” antidepressant responses in young personsFrontiers in Pharmacology, 2013
- Depression in adolescenceThe Lancet, 2012
- A Deficit in Peripheral Serotonin Levels in Major Depressive Disorder but Not in Chronic Widespread PainThe Clinical Journal of Pain, 2011
- Alterations in monoamine levels and oxidative systems in frontal cortex, striatum, and hippocampus of the rat brain during chronic unpredictable stressStress, 2010
- Peripheral and cerebral metabolic abnormalities of the tryptophan–kynurenine pathway in a murine model of major depressionBehavioural Brain Research, 2010
- Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphismJournal of Psychopharmacology, 2009
- A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depressionStress, 2008
- Childhood and adolescent depression: Why do children and adults respond differently to antidepressant drugs?Neurochemistry International, 2007
- Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studiesMolecular Psychiatry, 2007
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960